LY-393615 | Interleukin Related interleukin-related.com

Product Name :
LY-393615

Search keywords :
LY393615

drugId :
null

Target Vo:
Voltage-gated calcium channel

Target Vo Short Name :
VDCCs

Moa_Name:
Voltage-gated calcium channel blockers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Brain Ischemia

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATF6 Mouse mAb Epigenetics
Patritumab deruxtecan Data Sheet
BRD4 Antibody: BRD4 Antibody is an antibody about 152 kDa, targeting to BRD4.

Author: Interleukin Related

Related Posts